Back to Agendas
TRANSLATING REGULATORY APPROVAL INTO HEALTHCARE UPTAKE: THE NEXT CHALLENGE FOR BIOSIMILARS
Session Chair(s)
Virginia Acha, PhD, MSc
AVP, Global Regulatory Policy
Merck Sharp & Dohme LLC, United Kingdom
Incorporating the Patient Perspective into Clinical Decision Making in Type 2 Diabetes
Learning Objective : Participants will be able to: • Describe the key challenges of translation between regulatory approval and the inclusion of biosimilars in treatment across Europe. • Determine actions that can be taken to help overcome these challenges • Identify some of the measures already underway in Europe led by a range of stakeholders to better incorporate biosimilars in our healthcare
Speaker(s)
Mind the Gap: Setting out the translational challenges for biosimilars in healthcare settings
Virginia Acha, PhD, MSc
Merck Sharp & Dohme LLC, United Kingdom
AVP, Global Regulatory Policy
Translating from Approval to Uptake – the experiences of the first biosimilar mAb in Europe
Paul K. Audhya
Hospira UK, United Kingdom
Vice President, Medical Affairs Europe, Middle East, and Africa
Bridging the Gap for Hospital Pharmacist
Arnold Vulto, PharmD, PhD
Erasmus University Medical Center Rotterdam, Netherlands
Em. Professor of Hospital Pharmacy & Practical Therapeutics
Bridging the Gap for Clinicians
Richard Sullivan, MD, PhD
Kings College London, United Kingdom
Director Institute of Cancer Policy
Bridging the Gap for Patients
Alison Lightbourne
International Alliance of Patients’ Organizations (IAPO), United Kingdom
Policy Manager
Incorporating the Patient Perspective into Clinical Decision Making in Type 2 Diabetes
Matthew Reaney, PhD, MSc
IQVIA, United Kingdom
Head of Science and Analytics, Patient Centered Solutions
Have an account?